CEMI - Chembio Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue33,409.25124,015.42717,868.84124,255.485
Cost of Revenue29,953.49921,476.53817,845.05920,146.497
Gross Profit3,455.7522,538.88923.7824,108.988
Operating Expenses
Research Development8,526.2568,526.2568,526.2568,526.256
Selling General and Administrative11,100.7759,111.3637,595.5597,663.035
Non Recurring----
Others----
Total Operating Expenses41,054.27430,587.90125,440.61827,809.532
Operating Income or Loss-7,645.023-6,572.474-7,571.777-3,554.047
Income from Continuing Operations
Total Other Income/Expenses Net-288.147112.40925.548-3.238
Earnings Before Interest and Taxes-7,645.023-6,572.474-7,571.777-3,554.047
Interest Expense----0.836
Income Before Tax-7,933.17-6,460.065-7,546.229-3,557.285
Income Tax Expense-67.521-88.3055,800.818-1,160.243
Minority Interest----
Net Income From Continuing Ops-7,865.649-6,371.76-13,347.047-2,397.042
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,865.649-6,371.76-13,347.047-2,397.042
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,865.649-6,371.76-13,347.047-2,397.042